Corinna Miede
Sulzbach An Der Murr, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease.
Journal: Journal of the American Heart Association
Published: February 13, 2024
Risk of Malnutrition in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo-Controlled SENSCIS Trial.
Journal: Arthritis care & research
Published: February 23, 2023
Weight loss and outcomes in subjects with progressive pulmonary fibrosis: data from the INBUILD trial.
Journal: Respiratory research
Published: January 12, 2023
Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial.
Journal: Rheumatology (Oxford, England)
Published: October 11, 2021
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis.
Journal: Arthritis research & therapy
Published: May 25, 2021
Recanalization after cerebral venous thrombosis. A randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous and dural sinus thrombosis.
Journal: International journal of stroke : official journal of the International Stroke Society
Published: March 16, 2021
The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials).
Journal: Clinical cardiology
Published: February 20, 2021
Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: November 09, 2020
Dural Arteriovenous Fistulae After Cerebral Venous Thrombosis.
Journal: Stroke
Published: September 25, 2020
Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial.
Journal: JACC. Cardiovascular interventions
Published: September 21, 2020
Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: August 18, 2020
Last Updated: 09/26/2026